Relief Therapeutics Holding SA (SWX:RLF)

SWX:RLF Revenue

Relief Therapeutics Holding had revenue of 3.01M CHF in the half year ending December 31, 2023, a decrease of -9.36%. This brings the company's revenue in the last twelve months to 4.28M, down -50.19% year-over-year. In the year 2024, Relief Therapeutics Holding had annual revenue of 8.42M with 39.52% growth.

• Revenue (ttm): 4.28M
• Revenue Growth: -50.19%
• P/S Ratio: 8.24
• Revenue / Employee: 144.79K
• Employees: 31
• Market Cap: 33.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.42M	2.38M	39.52%
Dec 31, 2023	6.03M	-48.00K	-0.79%
Dec 31, 2022	6.08M	2.76M	83.11%
Dec 31, 2021	3.32M	-	-
Dec 31, 2020	-	-	-